Applicant, as named in the Orange Book

Polarean

Next listed expiry: Xenoview on 29 Dec 2035. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Xenoview NDA 214375 xenon xe-129 hyperpolarized	xenon xe-129 hyperpolarized	29 Dec 2035 patent	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.